DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, offering promising advancements across many health-related and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, more trustworthy option for therapeutic use, signi